Active Ingredient(s): Asenapine
FDA Approved: * October 11, 2019
Pharm Company: * HISAMITSU
Category: Antipsychotic

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Secuado Overview

Asenapine, sold under the brand name Saphris among others, is an atypical antipsychotic medication used to treat schizophrenia and acute mania associated with bipolar disorder.[2] It was chemically derived via altering the chemical structure of the tetracyclic (atypical) antidepressant, mianserin.[6] It was approved as a generic medication in the United States in 2020.[7] Contents 1 Medical uses 1.1 Schizophrenia 1.2 Acute mania 2 Adverse e...

Read more Secuado Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Secuado Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • System: 3.8mg/24hr, 5.7mg/24hr, 7.6mg/24hr
  • Tablet: 10mg, 2.5, 2.5mg, 5mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Secuado: (3 results)

Sorted by National Drug Code
  • 68968-0172 Secuado 3.8 mg/D Transdermal Film, Extended Release by Noven Therapeutics, LLC
  • 68968-0173 Secuado 5.7 mg/D Transdermal Film, Extended Release by Noven Therapeutics, LLC
  • 68968-0174 Secuado 7.6 mg/D Transdermal Film, Extended Release by Noven Therapeutics, LLC

Other drugs which contain Asenapine or a similar ingredient: (2 results)

Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 14 May 2021.

We are committed to your privacy.

Copyright © 2005-2021 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA